9 Meters Biopharma Price to Book Ratio

9 Meters Biopharma posts a P/B ratio of -0.07. That is below the Technology sector average of 18.78. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For Technology stocks, a P/B ratio near 18.78 is typical. 9 Meters Biopharma's -0.07 is lower that level. That is roughly 100.4% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

9 Meters Biopharma's P/B ratio of -0.07 comes from dividing a price-based measure by a related financial statistic. Changes can come from the stock price moving, the underlying fundamental shifting, or both. Track both the level and the trend — a rising multiple on falling fundamentals is a different story than a rising multiple on rising earnings.

Context for NMTR's P/B ratio usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 18.78), and (3) consistency with growth and profitability. This page covers the first two; 9 Meters Biopharma's other metric pages and overview cover the third.

Judging 9 Meters Biopharma against Technology peers is usually better than using a market-wide rule of thumb. Business models inside Technology are more comparable, which makes gaps in P/B ratio easier to interpret. Start with -0.07 here, then scan peer and history charts to see if the gap is persistent.